Diabetes Mellitus  >>  Tekturna (aliskiren)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00219089 / 2004-001062-40: A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

Completed
3
839
US, Europe
aliskiren
Novartis
Hypertension, Diabetes Mellitus
08/05
08/05
ALTITUDE, NCT00549757 / 2007-000860-25: Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

Checkmark P3 data
Aug 2012 - Aug 2012: P3 data
Checkmark P3 Data
Mar 2012 - Mar 2012: P3 Data
Terminated
3
8606
Europe, Canada, Japan, US, RoW
Aliskiren, Placebo
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus, Cardiovascular Disease
02/13
02/13

Download Options